标题
A Review of Autologous Stem Cell Transplantation in Lymphoma
作者
关键词
High-dose chemotherapy, Autologous stem cell transplantation, Relapsed/refractory, Lymphoma, Salvage chemotherapy, Novel agents
出版物
Current Hematologic Malignancy Reports
Volume 12, Issue 3, Pages 217-226
出版商
Springer Nature
发表日期
2017-05-06
DOI
10.1007/s11899-017-0382-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma
- (2017) Shinichi Makita et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies
- (2016) Seongseok Yun et al. ACTA HAEMATOLOGICA
- Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management
- (2016) Stephen M. Ansell AMERICAN JOURNAL OF HEMATOLOGY
- The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase
- (2016) Yu Ri Kim et al. ANNALS OF HEMATOLOGY
- Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review
- (2016) Josephine A. Taverna et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
- (2016) Elisabeth Schorb et al. BMC CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
- (2016) Pier Luigi Zinzani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- State-of-the-art Therapy for Advanced-stage Diffuse Large B-cell Lymphoma
- (2016) Annalisa Chiappella et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
- (2016) Olivier Hermine et al. LANCET
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Treatment of relapsed and refractory Hodgkin Lymphoma
- (2016) Bastian von Tresckow et al. SEMINARS IN HEMATOLOGY
- Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease
- (2015) Amer Beitinjaneh et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation
- (2015) Yi-Bin Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma
- (2015) Robert Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen
- (2015) Maurizio Musso et al. BRITISH JOURNAL OF HAEMATOLOGY
- Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
- (2015) David Sibon et al. HAEMATOLOGICA
- Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Craig H Moskowitz et al. LANCET
- PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study
- (2015) Alison J Moskowitz et al. LANCET ONCOLOGY
- Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
- (2015) Rosalba Camicia et al. Molecular Cancer
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autologous hematopoietic stem cell transplantation as late high-dose consolidation in adult patients with T-cell lymphoblastic leukemias: Results of a Russian multicenter study
- (2015) E. N. Parovichnikova et al. TERAPEVTICHESKII ARKHIV
- Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
- (2015) David Sibon et al. HAEMATOLOGICA
- Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
- (2014) Parastoo B. Dahi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
- (2014) F. Ellin et al. BLOOD
- Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
- (2014) Michael Crump et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma
- (2014) P Corradini et al. LEUKEMIA
- Outcomes after90Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis
- (2014) Sophie Auger-Quittet et al. Cancer Medicine
- Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial
- (2013) Julie M. Vose et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
- (2013) Patrick J. Stiff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Changing Landscape of Peripheral T-Cell Lymphoma in the Era of Novel Therapies
- (2013) Lionel Karlin et al. SEMINARS IN HEMATOLOGY
- Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
- (2012) Christian H. Geisler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Autologous Noncryopreserved Hematopoietic Stem Cell Transplant With CEAM as a Modified Conditioning Regimen in Patients With Hodgkin Lymphoma: A Single-center Experience With a New Protocol
- (2012) Mani Ramzi et al. Experimental and Clinical Transplantation
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
- (2012) Francesco d'Amore et al. JOURNAL OF CLINICAL ONCOLOGY
- BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
- (2011) G. Visani et al. BLOOD
- Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)
- (2011) Claire E. Dearden et al. BRITISH JOURNAL OF HAEMATOLOGY
- High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
- (2011) Franca Falzetti et al. CLINICAL AND EXPERIMENTAL MEDICINE
- A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
- (2011) W. H. Wilson et al. HAEMATOLOGICA
- The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study
- (2011) Catherine Thieblemont et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma
- (2010) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
- (2010) A. J. Moskowitz et al. BLOOD
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2010) N. Schmitz et al. BLOOD
- Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
- (2010) I Choi et al. BONE MARROW TRANSPLANTATION
- Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95
- (2010) Audrey Simon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary
- (2010) S. M. Malik et al. CLINICAL CANCER RESEARCH
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
- (2009) U. Vitolo et al. HAEMATOLOGICA
- Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation
- (2008) Nina Arakelyan et al. CANCER
- High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results
- (2008) A. M. Carella et al. HAEMATOLOGICA
- Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group
- (2008) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
- (2008) Peter Reimer et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search